| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
1B-Adrenergic Receptor Transgene Promotes Malignant Transformation of Thyroid Follicular Cells1
IRIBHN (C.L., J.D., G.V., M.P.) and the Medical Genetics Department (G.V.), Free University of Brussels Campus Erasme; and the Histology Laboratory, University of Louvain Medical School (J.-F.D.), Brussels, Belgium; and the Departments of Medicine and Biochemistry, Howard Hughes Medical Institute, Duke University Medical Center (S.C., R.L.), Durham, North Carolina 27710
Address all correspondence and requests for reprints to: Dr. Catherine Ledent, IRIBHN, Free University of Brussels Campus Erasme, 808 route de Lennik, B-1070 Brussels, Belgium.
Proliferation of thyroid follicular cells is controlled by three
intracellular cascades [cAMP, inositol 1,4,5-triphosphate
(IP3)/Ca2+/diacylglycerol (DAG), and tyrosine
kinases] that are activated by distinct extracellular signals and
receptors. We had previously generated a transgenic mouse model in
which the cAMP cascade was permanently stimulated in thyroid cells by
an adenosine A2a receptor (Tg-A2aR model). In
the present work, we have generated a transgenic model characterized by
the chronic stimulation of both adenylyl cyclase and phospholipase C in
thyroid follicular cells. The bovine thyroglobulin gene promoter was
used to direct the expression of a constitutively active mutant of the
1B adrenergic receptor, which is known to couple to both
cascades in transfected cell lines. The expression of the transgene
resulted, as expected, in the activation of phospholipase C and
adenylyl cyclase, as demonstrated by the direct measurement of
IP3 and cAMP in thyroid tissue. The phenotype resulting
from this dual stimulation included growth stimulation, hyperfunction,
cell degeneracy attributed to the overproduction of free radicals, and
the development of malignant nodules invading the capsule, muscles, and
blood vessels. Differentiated metastases were found occasionally in old
animals. The development of malignant lesions was more frequent and of
earlier onset than in our previous Tg-A2aR model, in which
only the cAMP cascade was stimulated. These observations demonstrate
that the cAMP and IP3/Ca2+/DAG cascades can
cooperate in vivo toward the development of thyroid
follicular cell malignancies.
This article has been cited by other articles:
![]() |
Y. Song, N. Driessens, M. Costa, X. De Deken, V. Detours, B. Corvilain, C. Maenhaut, F. Miot, J. Van Sande, M.-C. Many, et al. Roles of Hydrogen Peroxide in Thyroid Physiology and Disease J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3764 - 3773. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ribeiro-Neto, A. Leon, J. Urbani-Brocard, L. Lou, A. Nyska, and D. L. Altschuler cAMP-dependent Oncogenic Action of Rap1b in the Thyroid Gland J. Biol. Chem., November 5, 2004; 279(45): 46868 - 46875. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models Endocr. Rev., October 1, 2001; 22(5): 631 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Van Keymeulen, S. Deleu, J. Bartek, J. E. Dumont, and P. P. Roger Respective Roles of Carbamylcholine and Cyclic Adenosine Monophosphate in Their Synergistic Regulation of Cell Cycle in Thyroid Primary Cultures Endocrinology, March 1, 2001; 142(3): 1251 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. D. La Perle, S. M. Jhiang, and C. C. Capen Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid Carcinomas Am. J. Pathol., August 1, 2000; 157(2): 671 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, L. Duranteau, J.-C. Carel, J. Monroe, D. A. Doyle, and A. Shenker Leydig-Cell Tumors Caused by an Activating Mutation of the Gene Encoding the Luteinizing Hormone Receptor N. Engl. J. Med., December 2, 1999; 341(23): 1731 - 1736. [Full Text] [PDF] |
||||
![]() |
M. Derwahl, M. Broecker, and Z. Kraiem Thyrotropin May Not Be the Dominant Growth Factor in Benign and Malignant Thyroid Tumors J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 829 - 834. [Full Text] |
||||
![]() |
M. D. Ringel, M. Saji, W. F. Schwindinger, D. Segev, M. A. Zeiger, and M. A. Levine Absence of Activating Mutations of the Genes Encoding the {alpha}-Subunits of G11 and Gq in Thyroid Neoplasia J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 554 - 559. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |